Arkolith/Insider Trading/EXAS/Form 4

Baranick Brian

EVP, GM, Precision OncologyEXACT SCIENCES CORP (EXAS) · full profile →Form 4 · filed Mar 23, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 23, 2026Grant(A)33K—$0137K
Mar 23, 2026Disposed to issuer(D)795——0
Mar 23, 2026Disposed to issuer(D)137K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 23, 2026Disposed to issuer(D)28K——0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-118765) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML